Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

0.78

Margin Of Safety %

13

Put/Call OI Ratio

0.66

EPS Next Q Diff

0.69

EPS Last/This Y

EPS This/Next Y

0.57

Price

162.33

Target Price

168.94

Analyst Recom

2.17

Performance Q

4.87

Relative Volume

1.41

Beta

0.48

Ticker: JNJ




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-01-23JNJ146.60.580.26388378
2025-01-24JNJ146.820.570.72399313
2025-01-27JNJ152.890.580.25362654
2025-01-28JNJ150.390.590.57385754
2025-01-29JNJ151.130.600.44399457
2025-01-30JNJ152.820.600.18405327
2025-01-31JNJ152.190.580.39416367
2025-02-03JNJ151.820.580.39396336
2025-02-04JNJ153.480.580.29400702
2025-02-05JNJ154.680.570.35411715
2025-02-06JNJ153.510.560.46416624
2025-02-07JNJ153.140.560.41420110
2025-02-10JNJ154.240.560.25404329
2025-02-11JNJ156.120.550.66408694
2025-02-12JNJ155.240.580.30417169
2025-02-13JNJ157.280.580.29420386
2025-02-14JNJ156.110.580.07428722
2025-02-18JNJ155.260.660.42378811
2025-02-19JNJ157.90.660.33385241
2025-02-20JNJ159.690.650.12395199
2025-02-21JNJ162.230.660.30401486
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-01-23JNJ146.64-12.010011.89.96
2025-01-24JNJ146.76-12.08916.19.96
2025-01-27JNJ152.94-2.59984.810.51
2025-01-28JNJ150.44-2.710303.810.54
2025-01-29JNJ151.13-2.710891.410.54
2025-01-30JNJ152.87-2.611070.210.55
2025-01-31JNJ152.20-2.610750.510.55
2025-02-03JNJ151.87-2.610822.810.55
2025-02-04JNJ153.45-2.611166.510.55
2025-02-05JNJ154.62-2.611094.210.55
2025-02-06JNJ153.49-2.610657.210.55
2025-02-07JNJ153.14-2.610806.710.55
2025-02-10JNJ154.24-2.611079.910.55
2025-02-11JNJ156.15-2.611222.510.55
2025-02-12JNJ155.24-2.610714.210.55
2025-02-13JNJ157.25-2.611234.810.55
2025-02-14JNJ156.15-2.610677.810.55
2025-02-18JNJ155.01-2.611620.410.55
2025-02-19JNJ157.89-2.612589.110.55
2025-02-20JNJ159.68-2.612148.910.55
2025-02-21JNJ162.33-2.612298.410.57
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-01-23JNJ-0.160.790.68
2025-01-24JNJ-0.160.790.68
2025-01-27JNJ-0.160.770.68
2025-01-28JNJ-0.160.770.72
2025-01-29JNJ-0.160.770.72
2025-01-30JNJ-0.160.770.72
2025-01-31JNJ-0.160.770.72
2025-02-03JNJ-0.160.660.72
2025-02-04JNJ-0.130.660.72
2025-02-05JNJ-0.150.660.72
2025-02-06JNJ-0.150.660.72
2025-02-07JNJ-0.150.660.72
2025-02-10JNJ-0.150.610.72
2025-02-11JNJ-0.040.610.72
2025-02-12JNJ-0.140.610.78
2025-02-13JNJ-0.560.610.78
2025-02-14JNJ-0.560.610.78
2025-02-18JNJ-0.560.760.78
2025-02-19JNJ-0.440.760.78
2025-02-20JNJ-0.440.760.78
2025-02-21JNJ-0.500.760.78
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

2.04

Avg. EPS Est. Current Quarter

2.64

Avg. EPS Est. Next Quarter

2.73

Insider Transactions

-0.5

Institutional Transactions

0.76

Beta

0.48

Average Sales Estimate Current Quarter

21652

Average Sales Estimate Next Quarter

22443

Fair Value

183.67

Quality Score

95

Growth Score

80

Sentiment Score

85

Actual DrawDown %

13

Max Drawdown 5-Year %

-25.4

Target Price

168.94

P/E

28

Forward P/E

14.64

PEG

5.53

P/S

4.4

P/B

5.46

P/Free Cash Flow

19.69

EPS

5.8

Average EPS Est. Cur. Y​

10.57

EPS Next Y. (Est.)

11.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.84

Relative Volume

1.41

Return on Equity vs Sector %

0.4

Return on Equity vs Industry %

-7.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

12298.4
Johnson & Johnson
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 138100
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.
stock quote shares JNJ – Johnson & Johnson Stock Price stock today
news today JNJ – Johnson & Johnson stock forecast ,stock prediction 2023 2024 2025
marketwatch JNJ – Johnson & Johnson yahoo finance google finance
stock history JNJ – Johnson & Johnson invest stock market
stock prices JNJ premarket after hours
ticker JNJ fair value insiders trading